Advanced search
Publication Cover
Modern Rheumatology Volume 22, 2012 - Issue 3
Journal homepage
511
Views
62
CrossRef citations to date
0
Altmetric
Original Article

Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study

Shoichi OzakiDivision of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki 216-8511, JapanCorrespondence[email protected]
,
Tatsuya AtsumiDepartment of Medicine II, Clinical Immunology and Metabolism, Hokkaido University, Sapporo, Japan
,
Taichi HayashiDivision of Clinical Immunology, Graduate School of Comprehensive Human Science, University of Tsukuba, Tsukuba, Japan
,
Akihiro IshizuFaculty of Health Science, Hokkaido University, Sapporo, Japan
,
Shigeto KobayashiDivision of Rheumatology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan
,
Shunichi KumagaiDepartment of Clinical Pathology and Immunology, Kobe University Graduate School of Medicine, Kobe, Japan
,
Yasuyuki KuriharaDepartment of Radiology, St. Marianna University School of Medicine, Kawasaki, Japan
,
Manae S. KurokawaDivision of Clinical Proteomics and Molecular Medicine, St. Marianna University Graduate School of Medicine, Kawasaki, Japan
,
Hirofumi MakinoDepartment of Medicine and Clinical Science, Okayama University Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama, Japan
,
Hiroko NagafuchiDivision of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki 216-8511, Japan
,
Kimimasa NakabayashiThe First Department of Internal Medicine, Kyorin University School of Medicine, Mitaka, Japan
,
Norihiro NishimotoLaboratory of Immune Regulation, Wakayama Medical University, Wakayama, Japan
,
Machi SukaDepartment of Public Health and Environmental Medicine, The Jikei University School of Medicine, Tokyo, Japan
,
Yasuhiko TominoDivision of Nephrology, Department of Internal Medicine, Juntendo University, Tokyo, Japan
,
Hidehiro YamadaDivision of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki 216-8511, Japan
,
Kunihiro YamagataDepartment of Nephrology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan
,
Masaharu YoshidaDepartment of Nephrology, Tokyo Medical University Hachioji Medical Center, Hachioji, Japan
&
Wako YumuraDepartment of Nephrology, Jichi Medical University, Shimotsuke, Japan
 show all
Pages 394-404 | Received 04 Jul 2011, Accepted 22 Aug 2011, Published online: 02 Jan 2014

References

  • Jennette JC, Falk RJ. Clinical and pathological classification of ANCA-associated vasculitis: what are the controversies? Clin Exp Immunol. 1995;101(Suppl 1):18–22.
  • van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, et al. Autoantibodies against neutrophils and mono-cytes: tool for diagnosis and marker of disease activity in We-gener's granulomatosis. Lancet. 1985;1(8426):425–9.
  • Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulo-nephritis. N Engl J Med. 1988;318(25):1651–7.
  • Suzuki Y, Takeda Y, Sato D, Kanaguchi Y, Tanaka Y, Kobayashi S, et al. Clinicoepidemiological manifestations of RPGN and ANCA-associated vascufitides: an 11-year retrospective hospital-based study in Japan. Mod Rheumatol. 2009;20(1):54–62.
  • Falk RJ, Gross WL, Guillevin L, Hoffman G, Jayne DR, Jennette JC, et al. Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. Ann Rheum Dis. 2011;70(4):704.
  • Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992;116(6):488–98.
  • Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniene J, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoanti-bodies. N Engl J Med. 2003;349(1):36–44.
  • De Groot K, Rasmussen N, Bacon PA, Tervaert JW, Feighery C, Gregorini G, et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2005;52(8):2461–9.
  • Ozaki S. ANCA-associated vasculitis: diagnostic and therapeutic strategy. Allergol Int. 2007;56(2):87–96.
  • Koyama A, Yamagata K, Makino H, Arimura Y, Wada T, Nitta K, et al. A nationwide survey of rapidly progressive glomerulo-nephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol. 2009;13(6):633–50.
  • Flossmann 0, Bacon P, de Groot K, Jayne D, Rasmussen N, Seo P, et al. Development of comprehensive disease assessment in systemic vasculitis. Ann Rheum Dis. 2007;66(3):283–92.
  • Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage CO, et al. Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum. 1997;40(2): 371–80.
  • Fukuhara S, Suzukamo Y. Manual of SF-36v2 Japanese version. Kyoto: Institute for Health Outcomes and Process Evaluation Research; 2004.
  • Guillevin L, Lhote F, Gayraud M, Cohen P, Janousse B, Lortholary 0, et al. Prognostic factors in polyarteritis nodosa and Churg—Strauss syndrome. A prospective study in 342 patients. Medicine. 1996;75(1):17–28.
  • Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P. The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine. 2011;90(1):19–27.
  • Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD. ANCA-associated vasculitis with renal involvement: an outcome analysis. Nephrol Dial Transpl. 2004;19(6):1403–11.
  • Lapraik C, Watts R, Bacon P, Carruthers D, Chakravarty K, D'Cruz D, et al. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford). 2007;46(10):1615–6.
  • Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009;68(3):310–7.
  • Pagnoux C, Mahr A, Hamidou MA, Boffa JJ, Ruivard M, Ducroix JP, et al. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med. 2008;359(26):2790–803.
  • Hiemstra TF, Walsh M, Mahr A, Savage CO, de Groot K, Harper L, et al. Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial. JAMA. 2010;304(21): 2381–8.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.